Management of Metastatic Disease Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Management of Metastatic Disease. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Management of Metastatic Disease Indian Medical PG Question 1: Which substance plays a significant role in the tumor metastasis cascade?
- A. TNF-alpha
- B. CD99
- C. NM23
- D. MMP-2 (Matrix Metalloproteinase-2) (Correct Answer)
Management of Metastatic Disease Explanation: ***Collagenase IV***
- Collagenase IV is involved in the **degradation of extracellular matrix**, facilitating tumor invasion and metastasis [1,2].
- It plays a crucial role in breaking down **type IV collagen**, a major component of the **basement membrane**, allowing cancer cells to migrate [2].
*TNF-alpha*
- While TNF-alpha is a cytokine that can promote **tumor growth**, it is not directly involved in the **metastatic cascade** like collagenase IV [3,4].
- It primarily functions in **inflammation** and immune response, affecting tumor microenvironment rather than directly facilitating invasion.
*NM23*
- NM23 is noted for its potential role as a **tumor suppressor**, and lower levels are associated with metastasis.
- However, it does not play a direct role in the *metastatic cascade* itself [3,4], as it primarily influences **tumor progression** rather than matrix degradation.
*CD99*
- CD99 is a cell adhesion molecule implicated in **cell migration**, but it is not a significant factor in the **enzymatic breakdown** of tissue during metastasis [1,2].
- Its expression has more to do with **cell adhesion characteristics**, rather than directly promoting invasive capabilities.
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 315-316.
[2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 232-233.
[3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 314-315.
[4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 233-234.
Management of Metastatic Disease Indian Medical PG Question 2: Gold standard investigation for breast carcinoma screening in a patient with silicone breast implants
- A. Mammography
- B. CT scan
- C. USG
- D. MRI (Correct Answer)
Management of Metastatic Disease Explanation: ***MRI***
- **MRI** is considered the **gold standard** for breast cancer screening in patients with silicone breast implants due to its superior ability to visualize breast tissue through the implant and detect subtle lesions.
- It offers **high sensitivity** in detecting both implant rupture and early malignancies, often providing better clarity than mammography in augmented breasts where implants can obscure tissue.
*Mammography*
- While a standard screening tool, **mammography** can be limited in patients with silicone implants because the implants can **obscure adjacent breast tissue**, making detection of small masses challenging.
- Special views (e.g., **Eklund views**) can be used, but sensitivity is still reduced compared to MRI in augmented breasts.
*CT scan*
- **CT scans** are not routinely used for primary breast cancer screening due to their use of **ionizing radiation** and lower sensitivity for detecting early breast lesions compared to MRI.
- CT is more commonly used for **staging** advanced cancers or evaluating complex masses detected by other modalities.
*USG*
- **Ultrasound (USG)** is a valuable complementary tool, especially for evaluating palpable lumps or clarifying findings from mammography, but it is **operator-dependent** and has a lower overall sensitivity for general screening compared to MRI.
- It is particularly useful for differentiating between **cystic and solid masses** and detecting implant ruptures but is not the gold standard for comprehensive screening in augmented breasts.
Management of Metastatic Disease Indian Medical PG Question 3: The following procedure is performed for the management of?
- A. Gallbladder carcinoma
- B. Distal cholangiocarcinoma (Correct Answer)
- C. Chronic calcific pancreatitis
- D. Advanced gastric carcinoma
Management of Metastatic Disease Explanation: ***Distal cholangiocarcinoma***
- The image shows a **Pylorus-preserving Whipple procedure (PPPD)**, which involves resection of the pancreatic head, duodenum, gallbladder, and part of the common bile duct, followed by reconstruction.
- This procedure is primarily performed for malignancies of the **pancreatic head**, **distal bile duct (cholangiocarcinoma)**, and **ampulla of Vater**, as they often cause obstructive jaundice and are resectable.
*Gallbladder carcinoma*
- While gallbladder carcinoma can involve the bile ducts, this specific reconstruction (PPPD) is more commonly associated with tumors of the pancreatic head or distal bile duct rather than the gallbladder itself, which might be managed with a **cholecystectomy** and possibly **liver resection**.
- The type of resection and reconstruction varies significantly based on the extent and location of gallbladder cancer.
*Chronic calcific pancreatitis*
- Surgical management for chronic pancreatitis, especially with calcifications, typically involves drainage procedures (e.g., **Puestow procedure** due to dilated pancreatic duct or **Frey procedure**) or resection of the pancreatic head (e.g., **Beger procedure**).
- While some resections of the pancreatic head are performed for chronic pancreatitis, the depicted procedure is specifically designed for malignancies of the pancreatic head region, not primarily for the sequelae of chronic calcific pancreatitis unless associated with a mass suspicious for malignancy.
*Advanced gastric carcinoma*
- Advanced gastric carcinoma is typically managed by **gastrectomy** (partial or total) with lymphadenectomy, not a Whipple procedure.
- The image clearly shows an **intact pylorus** and the stomach mostly preserved, which is inconsistent with advanced gastric carcinoma requiring major gastric resection.
Management of Metastatic Disease Indian Medical PG Question 4: In prostatic metastasis, the site most commonly involved is which one?
- A. Perivesical nodes
- B. Obturator nodes (Correct Answer)
- C. Pre-sacral nodes
- D. Para-aortic nodes
Management of Metastatic Disease Explanation: ***Obturator nodes***
- The **obturator nodes** are a primary site for metastatic spread from the prostate due to their close proximity and direct lymphatic drainage pathways.
- Prostate cancer cells often spread via the **lymphatic system** to regional lymph nodes before disseminating to distant sites.
**Perivesical nodes**
* While also regional, perivesical nodes are less frequently the _initial_ or most common site of metastasis compared to the obturator and internal iliac nodes.
* Lymphatic drainage from the prostate primarily follows pathways that lead to obturator and internal iliac nodes first.
**Pre-sacral nodes**
* Pre-sacral nodes are considered more distant regional nodes compared to the obturator nodes and are typically involved later in the metastatic process.
* Their involvement often indicates a more advanced stage of nodal metastasis.
**Para-aortic nodes**
* Para-aortic nodes are considered distant metastases for prostate cancer, indicating widespread disease.
* Metastasis to para-aortic nodes usually occurs after involvement of more proximal regional nodes like the obturator and internal iliac nodes.
Management of Metastatic Disease Indian Medical PG Question 5: The most common site of metastasis in neuroblastoma is?
- A. Lung
- B. Liver
- C. Lymph nodes
- D. Bone marrow (Correct Answer)
Management of Metastatic Disease Explanation: ***Bone marrow***
- **Bone marrow** is the most common site of metastasis in neuroblastoma, occurring in more than half of all patients and being a primary determinant of prognosis.
- Metastasis to the bone marrow often leads to **anemia**, **thrombocytopenia**, and sometimes **bone pain**.
*Lung*
- While possible, lung metastases are relatively **uncommon** in neuroblastoma, especially when compared to bone marrow involvement.
- Lung metastases tend to occur in **later stages** or with specific genetic subtypes.
*Liver*
- Liver metastases, though seen, are more prevalent in **infants** with **Stage 4S neuroblastoma**, where the liver can be massively enlarged [1].
- This specific stage often has a **better prognosis** than other metastatic forms [1].
*Lymph nodes*
- **Regional lymph node** involvement is common at diagnosis, but distant lymph node metastasis is less frequent than bone marrow involvement.
- Involvement of regional lymph nodes does contribute to staging but is not the most frequent site of **distant metastasis**.
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, p. 486.
Management of Metastatic Disease Indian Medical PG Question 6: In the context of solid tumors, which is the most common site of metastasis?
- A. Lung (Correct Answer)
- B. Bone
- C. Liver
- D. Brain
Management of Metastatic Disease Explanation: ***Lung***
- The **lungs** are the most common site of metastasis for solid tumors overall due to their unique position in receiving 100% of the systemic venous return via the pulmonary circulation.
- This makes the lungs the **first capillary bed** encountered by tumor cells entering the venous system from most primary sites.
- Common primary tumors metastasizing to lung include **breast, colon, kidney, sarcomas, melanoma, head and neck, and thyroid cancers** [2].
- Found in approximately **30-40% of all cancer deaths** at autopsy.
*Liver*
- The **liver** is the **second most common** site for metastasis, particularly for gastrointestinal malignancies [1].
- Its dual blood supply (hepatic artery and portal vein) makes it highly susceptible, especially for tumors draining via the **portal circulation** (colon, pancreas, stomach).
- Also a common site for breast, lung, and melanoma metastases.
- Found in approximately 30-35% of cancer deaths at autopsy.
*Bone*
- **Bone metastases** are common with specific tumor types: breast, prostate, lung, kidney, and thyroid [3].
- While causing significant morbidity (pain, fractures, hypercalcemia), bone is **less frequent overall** compared to lung or liver when considering all solid tumors.
*Brain*
- **Brain metastases** occur primarily with lung cancer, breast cancer, melanoma, and renal cell carcinoma [1].
- The **blood-brain barrier** provides some protection, making brain a less common site overall.
- Significant clinical impact but lower overall frequency compared to lung and liver.
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 724-725.
[2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 338-339.
[3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 671-672.
Management of Metastatic Disease Indian Medical PG Question 7: Which is the most common site for colorectal cancer metastasis?
- A. Liver (Correct Answer)
- B. Brain
- C. Peritoneum
- D. Lungs
Management of Metastatic Disease Explanation: ***Liver***
- The liver is the **most common site** for colorectal cancer metastasis due to its direct vascular connection via the **portal venous system**.
- Blood from the colon and rectum drains into the **portal vein**, which then carries cancer cells directly to the liver.
*Brain*
- While brain metastases can occur, they are **relatively rare** and typically late manifestations in the course of colorectal cancer.
- The brain is **not the primary organ** for initial metastatic spread from colorectal cancer.
*Peritoneum*
- **Peritoneal carcinomatosis** is a significant mode of spread, especially in advanced colorectal cancer, but it is **less common** than liver metastasis.
- This type of spread involves the **lining of the abdominal cavity**, often leading to ascites and bowel obstruction.
*Lungs*
- **Pulmonary metastasis** is the **second most common** site for colorectal cancer after the liver.
- Cancer cells reaching the lungs usually do so via the **systemic circulation** after passing through or bypassing the liver.
Management of Metastatic Disease Indian Medical PG Question 8: What is the best marker to assess prognosis after surgery for colon carcinoma?
- A. CA 19-9
- B. CA-125
- C. Alpha fetoprotein
- D. CEA (Correct Answer)
Management of Metastatic Disease Explanation: ***CEA***
- Carcinoembryonic antigen (**CEA**) is a well-established tumor marker for monitoring colorectal cancer post-surgery and assessing prognosis [1].
- Elevated **CEA levels** after surgery may indicate recurrence or residual disease, making it valuable in follow-up care [1].
*CA 19-9*
- Primarily associated with **pancreatic** and **biliary tract cancers**, and not specific for colon carcinoma.
- While it may elevate in some gastrointestinal malignancies, it is not the best indicator for prognosis after colon cancer surgery.
*Alpha fetoprotein*
- Mostly used for monitoring **hepatocellular carcinoma** and germ cell tumors, not colorectal malignancies.
- Elevated levels are not typically correlated with prognosis in colon cancer patients.
*CA-125*
- Mainly utilized as a tumor marker for **ovarian cancer** and some other malignancies, not specifically for colon carcinoma.
- Its use in colorectal cancer prognosis is limited and lacks relevance in this context.
**References:**
[1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 253-254.
Management of Metastatic Disease Indian Medical PG Question 9: A patient presents with a penile lesion staged as T3, with clinically palpable lymph nodes. What is the most appropriate management?
- A. Penectomy
- B. Penectomy with superficial node dissection
- C. Penectomy with deep ilioinguinal node dissection (Correct Answer)
- D. Chemoradiotherapy
Management of Metastatic Disease Explanation: ***Penectomy with deep ilioinguinal node dissection***
- A **T3 penile lesion** indicates invasion of the corpus cavernosum or corpus spongiosum, which is an aggressive stage requiring **radical local excision (penectomy)**.
- **Clinically palpable lymph nodes** alongside a T3 tumor suggest nodal involvement (N1-N3), necessitating a **deep ilioinguinal lymph node dissection** to remove affected deeper lymph nodes that are not readily accessible by superficial dissection.
*Penectomy*
- While penectomy addresses the primary tumor, it does not manage the **clinically palpable lymph nodes**, which are crucial for staging and prognosis in advanced penile cancer.
- This option would be insufficient given the documented **nodal involvement**, leading to likely recurrence and progression of the disease.
*Penectomy with superficial node dissection*
- This approach is inadequate for **palpable lymph nodes**, especially with a T3 lesion, because such nodes often indicate involvement of **deeper lymphatics (deep ilioinguinal)**.
- Superficial dissection alone would likely leave residual disease, failing to properly stage and treat the extent of the cancer.
*Chemoradiotherapy*
- **Chemoradiotherapy** is typically reserved for patients who are not surgical candidates, or as a neoadjuvant/adjuvant therapy, not as primary treatment for a **T3 lesion with palpable nodes** where surgical intervention is the standard of care for optimal local and regional control.
- While it may be used in certain settings, surgery (penectomy with lymph node dissection) offers the best chance for cure in this scenario.
Management of Metastatic Disease Indian Medical PG Question 10: Clinical examination of a symptomatic patient shows a Sister Mary Joseph nodule. It is most commonly associated with which of the following?
- A. Ovarian cancer
- B. Stomach cancer (Correct Answer)
- C. Colon cancer
- D. Pancreatic cancer
Management of Metastatic Disease Explanation: ***Stomach cancer***
- A **Sister Mary Joseph nodule** is a **periumbilical metastatic nodule**, most commonly associated with **gastric adenocarcinoma** due to its propensity for peritoneal spread.
- While it can originate from other abdominal malignancies, stomach cancer is statistically the most frequent primary source of this metastatic sign.
*Ovarian cancer*
- Ovarian cancer can metasatasize to the peritoneum and sometimes cause Sister Mary Joseph nodules, but it is not the most common primary source [1].
- Instead, ovarian cancer more frequently presents with symptoms like **abdominal distension**, **pelvic pain**, or **ascites** [1].
*Colon cancer*
- **Colorectal cancer** can also metastasize to the peritoneum, potentially leading to a Sister Mary Joseph nodule, though less commonly than gastric cancer [2].
- It often manifests with changes in **bowel habits**, **rectal bleeding**, or **unexplained weight loss** [2].
*Pancreatic cancer*
- Pancreatic cancer can produce a Sister Mary Joseph nodule, particularly in advanced stages with **peritoneal dissemination**.
- However, it is primarily known for other metastatic patterns and often presents with **jaundice** (if the head of the pancreas is affected) or **epigastric pain**.
More Management of Metastatic Disease Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
